1.
William Johnson, Anjali Mishra, Adam Binder, Alejandro Gru, Pierluigi Porcu. Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?. haematol [Internet]. 2019May1 [cited 2023Jan.28];104(5):864-7. Available from: https://haematologica.org/article/view/8888